SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (5761)12/10/1998 1:50:00 PM
From: David S.  Respond to of 6136
 
Predictions for next few weeks...a total of 5 department store Santa's will be arrested for fondling children, 19 people will die in car accidents due to alcohol in the states of Florida, Nebraska, and Missouri, inclusive...Clinton stays in office and is so happy that he is caught playfully spanking Hillary on the tushie, Japan comes out and tells the world the following, "Excuse us, but we really have no clue why we are so *ucked up, and we don't know what to do to get out of this, but we will keep nodding our heads and depleting the world's oceans of bluefin tuna, and eventually maybe everything will be ok, yes?"



To: Steve Fancy who wrote (5761)12/10/1998 6:45:00 PM
From: Henry Niman  Respond to of 6136
 
I was busy with Merger Mania yesterday, but Paine Webber came out with a reiterated BUY on AGPH and raised its target from $50 to $65. Details in New Therapeutics page in anti-HIV table at biocognizance.com. I also have indexed AGPH and included a background table and link to their home page.
PW also reiterated ATTRACTIVE on BCHE and raised target to $30 from $25.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News